MedPath

Effect of Nigella sativa seed administration on prevention of neutropenia during chemotherapy among children with blood cancer

Phase 3
Recruiting
Conditions
Acute lymphoblastic leukemia.
Acute lymphoblastic leukemia [ALL]
C91.0
Registration Number
IRCT20191009045035N1
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
88
Inclusion Criteria

Children aged 3 to 15 yearsWith cancer undergoing chemotherapy
No other concomitant diseases

Exclusion Criteria

Congenital or acquired immunodeficiency
Drug Sensitivity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete Blood Count. Timepoint: every week. Method of measurement: sampling.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath